Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. [electronic resource]
Producer: 20160802Description: 693-8 p. digitalISSN:- 1874-1754
- Atrial Fibrillation -- complications
- Dose-Response Relationship, Drug
- Europe -- epidemiology
- Factor Xa Inhibitors -- administration & dosage
- Female
- Humans
- Incidence
- Male
- Models, Theoretical
- Population Surveillance
- Pyridines -- administration & dosage
- Retrospective Studies
- Risk Assessment -- methods
- Risk Factors
- Stroke -- epidemiology
- Survival Rate -- trends
- Thiazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.